Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children

This study is developing and testing a treatment protocol for children newly diagnosed with acute monocytic leukemia (M5), a specific type of acute myeloid leukemia (AML) that mainly affects young children and can be aggressive. **You may be eligible if...** - You are a child between 0 and 14 years old - You have been diagnosed with acute monocytic leukemia (M5 subtype) confirmed by bone marrow analysis **You may NOT be eligible if...** - Your leukemia developed as a result of another condition (like an immune deficiency or myelodysplastic syndrome) - You have a second separate cancer - You have Down syndrome - Your leukemia developed from chronic myelogenous leukemia progressing to blast crisis - You die or stop treatment within the first 7 days of starting induction therapy - You are already being treated with other effective chemotherapy drugs for AML (other than drugs given to lower very high white blood cell counts) - You have severe uncontrolled heart, brain, liver, or kidney failure Talk to your doctor to see if this trial is right for you.